On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases.
alpha2-plasmin inhibitor is a proteinase inhibitor in plasma which efficiently inhibits the lysis of fibrin clots induced by plasminogen activator. The nature of the binding of the inhibitor to trypsin or plasmin was studied by the chemical treatment of the enzyme-inhibitor complex with 7.5 M hydrazine at pH 10.0. With the hydrazine treatment, the complexes were degraded to proteins corresponding to the respective enzyme and inhibitor moieties. These results indicate that the covalent bond between the inhibitor and the enzymes is a carboxylic ester. The binding reaction of the inhibitor to active site-modified trypsin was also studied. The inhibitor formed complexes with anhydrotrypsin and carboxyamidomethylated trypsin. The complexes were dissociated in the presence of 1% sodium dodecyl sulfate, to the individual components: the respective enzyme and inhibitor moieties. The inhibitor, however, did not form a complex with diisopropylphosphorylated trypsin regardless of the presence or absence of the denaturing reagent. These results suggest the contribution of non-covalent interactions to the complex formation between the inhibitor and native enzymes.
D001665:Binding Sites; D001798:Blood Proteins / Q000302:isolation & purification / Q000494:pharmacology; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D006834:Hydrazines; D007531:Isoflurophate; D046911:Macromolecular Substances; D008970:Molecular Weight; D011485:Protein Binding; D014357:Trypsin / Q000378:metabolism
D001798:Blood Proteins; D006834:Hydrazines; D046911:Macromolecular Substances; D007531:Isoflurophate; D014357:Trypsin; D005341:Fibrinolysin